Scientific Sessions 2025  /  Updates in Diabetes Cardiovascular Outcome Trials  /  Making STRIDEs in diabetes: the role of incretin-based therapy in peripheral artery disease
Logo

American Heart Association

  38
  0

Final ID:

Making STRIDEs in diabetes: the role of incretin-based therapy in peripheral artery disease

  • Bonaca, Marc  ( CPC Clinical Research , Aurora , Colorado , United States )
  • Verma, Subodh  ( ST MICHAELS HOSPITAL , Toronto , Ontario , Canada )
    • Author Disclosures:
    Marc Bonaca: DO have relevant financial relationships ; Employee:CPC Clinical Research:Active (exists now) ; Consultant:Prairie Education and Research Cooperative, Prothena Biosciences Limited, Regeneron Pharmaceuticals, Inc., Regio Biosciences, Inc., Sanofi-Aventis Groupe, Silence Therapeutics PLC, Smith & Nephew plc, Stealth BioTherapeutics Inc., VarmX, Virta Health Corporation.:Active (exists now) ; Consultant:Medimmune Ltd., Merck & Affiliates, Nectero Medical Inc., Novartis Pharmaceuticals Corp., Novo Nordisk, Inc., Osiris Therapeutics Inc., Pfizer Inc., PhaseBio Pharmaceuticals, Inc.:Active (exists now) ; Consultant:Exicon Consulting Pvt. Ltd., Faraday Pharmaceuticals, Inc., Foresee Pharmaceuticals Co. Ltd., Fortress Biotech, Inc., HDL Therapeutics Inc., HeartFlow Inc., Hummingbird Bioscience, Insmed Inc., Ionis Pharmaceuticals, Janssen and Affiliates, Kowa Research Institute, Inc., Lexicon Pharmaceuticals, Inc.:Active (exists now) ; Consultant:Bayer and Affiliates, Bristol-Meyers Squibb Company, Cambrian Biopharma, Inc., Cardiol Therapeutics Inc., CellResearch Corp., Cleerly Inc., Cook Regentec LLC, CSL Behring LLC, Eidos Therapeutics, Inc., EP Trading Co. Ltd., Epizon Pharma, Inc., Esperion Therapeutics, Inc., Everly Well, Inc.:Active (exists now) ; Consultant:Abbott Laboratories, Agios Pharmaceuticals, Inc., Alexion Pharma, Alnylam Pharmaceuticals, Inc., Amgen Inc., Angionetics, Inc., Anthos Therapeutics, Array BioPharma, Inc., AstraZeneca and Affiliates, Atentiv LLC, Audentes Therapeutics, Inc.:Active (exists now) | Subodh Verma: DO have relevant financial relationships ; Researcher:Amgen:Active (exists now) ; Speaker:Amgen:Active (exists now) ; Consultant:Amgen:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Updates in Diabetes Cardiovascular Outcome Trials

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Integrating lessons learned from diabetes CVOTs (old and new) into clinical care

Taub Pam, Gianos Eugenia

Will dual GIP and GLP1 receptor agonism SURPASS existing GLP1RAs?

Sattar Naveed, Nicholls Stephen

More abstracts from these authors:
Antithrombotic prophylaxis in patients with peripheral arterial disease

Bonaca Marc, Creager Mark

Discussant: CLEAR SYNERGY

Bonaca Marc

You have to be authorized to contact abstract author. Please, Login
Not Available